Fundraising FoxBEVC — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Addition Therapeutics is a biotechnology company developing therapeutics, led by a scientific and clinical team.
BiotechHealthtechSouth San Francisco, US
Kathleen Collins(Director)inLawrence Kong(Executive Officer)inRon Park(President & CEO)inFrancine Gregoire(Chief Scientific Officer)inPriya Parameswaran(Chief Business Officer)in
BoardJayson Punwani(Director)in
Co-investorsPivotal Life SciencesSR One Capital ManagementAbingworth
Khemia Metals develops earth-abundant alloys intended to replace critical metals in battery production, aiming to make batteries lighter, cheaper, and more sustainable.
CleantechEnergyNew MaterialsSan Carlos, US
Helen Bergstrom(Executive Officer, Director)Brian Hardin(Executive Officer, Director)
BoardJoshua James(Director)David Schroeder(Director)
Co-investorsBaruch Future VenturesDangerous Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.